The
Company’s outstanding and exercisable warrants as of September 30, 2024 are presented below:
Schedule
of Warrants Outstanding and Exercisable
|
|
Number of Warrants
|
|
|
Weighted Average Exercise Price
|
|
Warrants outstanding at December 31, 2023 |
|
|
260,995 |
|
|
$ |
82.55 |
|
Issued |
|
|
530,329 |
|
|
|
0.90 |
|
Expired |
|
|
(43,862 |
) |
|
|
89.60 |
|
Warrants outstanding at September 30, 2024 |
|
|
747,462 |
|
|
|
22.98 |
|
Warrants Outstanding |
|
|
Exercise Price |
|
|
Expiration Date |
|
10,888 |
|
|
$ |
186.00 |
|
|
11/8/2024 |
|
153,334 |
|
|
$ |
75.00 |
|
|
5/1/2025 |
|
52,911 |
|
|
$ |
60.00 |
|
|
7/17/2025 |
|
70,000 |
|
|
$ |
1.88 |
|
|
2/27/2029 |
|
55,000 |
(1)
|
|
$ |
1.25 |
|
|
6/29/2029 |
|
405,329 |
(2)
|
|
$ |
0.69 |
|
|
9/4/2029 |
|
1,139,705 |
(3)
|
|
$ |
0.001 |
|
|
|
|
1,887,167 |
|
|
|
|
|
|
|
All
outstanding warrants are classified as equity on the Company’s Condensed Consolidated Balance Sheets.
(1) |
–
Dawson James Placement Agent warrants are not exercisable until December 23, 2024. |
(2) |
–
Dawson James Placement Agent warrants are not exercisable until March 4, 2025. |
(3) |
– Pre-Funded Warrants from September 5, 2024 financing not yet converted
as of November 13, 2024. |
|